Multiple dose levels

From: Paul Hutson Date: September 28, 2001 technical Source: cognigencorp.com
From: Paul Hutson <prhutson@pharmacy.wisc.edu> Subject: Multiple dose levels Date: Fri, 28 Sep 2001 12:57:53 -0500 I am analyzing Phase I data from patients treated at multiple (4) dose levels (LVL). Is there a convenient means of having analysis skip records for all patients except those with a desired dose level so that THETAs for a given dose level can be determined separately? Is it preferred to just set up separate data files for each level? Thanks, everyone. Have a great weekend. Paul Paul Hutson, Pharm.D. Associate Professor (CHS) UW School of Pharmacy NOTE NEW ADDRESS effective 6/2001 777 Highland Avenue Madison, WI 53705-2222 Tel: (608) 263-2496 FAX: (608) 265-5421 Pager: (608) 265-7000, #7856
Sep 28, 2001 Paul Hutson Multiple dose levels
Sep 28, 2001 Joern Loetsch Re: Multiple dose levels
Oct 01, 2001 Lewis B. Sheiner Re: Multiple dose levels